Saturday, February 22, 2025, 12:46AM |  27°
MENU
Advertisement
Kristin Grant, a microbiologist on the COVID-19 team at the Washington State Department of Health's Public Health Laboratory, loads samples that tested positive for COVID-19 into a machine that prepares them for automated genome sequencing on Dec. 7 in Shoreline, Wash.
2
MORE

Pennsylvania's capacity to track coronavirus variants is lagging

Associated Press

Pennsylvania's capacity to track coronavirus variants is lagging

As the highly contagious omicron variant of the coronavirus spreads throughout the United States, Pennsylvania is lagging behind in its ability to detect cases caused by the new strain.

As of Thursday, only one case of omicron has been identified in Pennsylvania — in Philadelphia — but that may be because the state is sequencing so few samples from patients who test positive for the virus. In recent months, Pennsylvania has been one of the states doing the least amount of sequencing per positive cases. Pennsylvania and six other states — Alabama, Kentucky, Missouri, Ohio, Oklahoma and South Dakota — have the lowest rates over the last 90 days, having each sequenced and reported fewer than 3% of its COVID-19 cases, according to the open-source website GISAID.

While the delta variant still accounts for the majority of COVID-19 cases in Pennsylvania and elsewhere across the country, omicron will likely outpace delta and become the dominant strain at some point in January, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, during a Dec. 16 event held by the U.S. Chamber of Commerce Foundation. Omicron currently makes up an estimated 3% of cases nationally. With COVID-19 cases once again rising in Western Pennsylvania, it’s unclear how many infections may involve the new omicron variant.

Advertisement

“We use sequencing to track these variants and also to study transmission — how the virus is being spread from person to person,” Dr. Lee Harrison, professor of infectious diseases and epidemiology at the University of Pittsburgh, said in an interview.

Charmaine Pykosh, a nurse practitioner at UPMC Presbyterian, who was the first person in Pittsburgh to receive a COVID-19 vaccine on Dec. 14, 2020, stands outside of her Fox Chapel home one year later on Dec. 14, 2021.
Jesse Bunch
She was the first vaccinated in Pittsburgh. One year later, has anything changed?

Tracking which variants are causing disease is also important for understanding whether vaccines and treatments against COVID-19 are still working. Early data shows that our current vaccines, as well as monoclonal antibodies treatments, may be less effective against omicron.

Standard PCR and antigen tests are used to determine whether a person is infected with SARS-CoV-2, the virus that causes COVID-19, but they can’t tell what variant someone has. For that, you need a more complex type of test called sequencing, which provides a readout of an organism’s entire genetic code. SARS-CoV-2’s genetic code is about 30,000 letters long (by comparison, the human genome is 6 billion letters long).

Sequencing allows scientists to compare one genome to another in order to spot differences. When enough differences or mutations in the virus’s genetic code are found, scientists may identify that as a variant. The omicron variant has dozens of mutations — essentially misspellings — in its 30,000-letter genetic code that change the behavior of the virus.

Advertisement

Sequencing can only be performed on specialized sequencing machines, whereas PCR and antigen are standard tests performed by most labs. Sequencing the SARS-CoV-2 virus takes about 40 to 60 hours, said Dr. Harrison, who runs a sequencing lab at Pitt.

“This type of genomic surveillance is really important to understand exactly what variants are causing disease in the population,” said Dr. Harrison, whose lab conducts sequencing mainly for research purposes.

Because of the time and equipment needed to sequence SARS-CoV-2 samples, only a portion of positive cases are sequenced in Pennsylvania and around the country. UPMC says it does not routinely sequence patient samples because knowing if they have delta or omicron doesn’t change clinical treatment.

Overall, only about 2.4% of Pennsylvania’s nearly 1.9 million total confirmed coronavirus cases have been sequenced, according to CDC data last updated on Dec. 14. By comparison, neighboring West Virginia has sequenced 8.6% and Maryland has sequenced about 6.5%.

People wait in line at a COVID-19 testing site Monday in Times Square, New York. Cases of the omicron variant of the coronavirus are expected to rise next month after families gather for the holidays, White House officials said Wednesday, citing new data that suggests the variant is highly transmissible but can be blunted by vaccine booster shots.
Laura Ungar and Carla K. Johnson
U.S. faces a double coronavirus surge as omicron advances

Up until this summer, Pennsylvania did not have the resources to sequence SARS-CoV-2 samples internally, Maggi Barton, a spokeswoman for the Pennsylvania Department of Health, said in an email. Before that, the CDC and labs it contracts with performed SARS-CoV-2 sequencing for the state.

In July, Pennsylvania began doing its own sequencing at its state public health lab in Exton after receiving $7.1 million in federal funds from a Biden administration initiative to boost the country’s ability to track emerging variants. Currently, Pennsylvania can sequence at least 64 samples of SARS-CoV-2 a week, according to Ms. Barton. In addition, the state health department is shipping at least 36 samples every other week to the CDC as part of the agency’s national surveillance program.

“The Department of Health continues to stay alert and build capacity by training staff and procuring additional instrumentations as COVID-19 variants continue to emerge,” Ms. Barton said. The state lab also is hiring additional laboratory scientists to help increase its sequencing capacity.

Kelly Wroblewski, director of infectious diseases at the Association of Public Health Laboratories, said in a Dec. 8 briefing with reporters that staffing issues in sequencing labs remain a problem across the country.

Nationally, between 5 to10% of positive COVID-19 samples are being sequenced, up from less than 1% early in the pandemic. While that is an improvement, experts say more sequencing would allow public health officials to better understand how omicron and other variants are spreading.

“We would like to see somewhere on the order of 15 to 30 percent,” said Dr. Celine Gounder, an epidemiologist and infectious diseases specialist at New York University, in an interview. “We’ve dramatically ramped up the volume of testing, but we're not quite where we need to be and it's still a bit patchy across the country.”

The number of positive cases being sequenced varies greatly from state to state. For instance, Vermont has sequenced 22% of its COVID-19 cases, Wyoming has sequenced nearly 21% and Colorado has sequenced nearly 13%, according to CDC data.

Some states had sequencing capabilities before the COVID-19 pandemic hit the United States in early 2020, allowing them to adapt quickly and start sequencing SARS-CoV-2 samples from patients.

For instance, Minnesota’s public health lab, which has sequenced about 9% of cases, has been doing sequencing “in full force” since 2016.

“That allowed us to actually start sequencing for SARS-CoV-2 about a month after our first positive case was detected in March of 2020,” Myra Kunas, interim division director at Minnesota Department of Health’s Public Health Lab, said in the Dec. 8 briefing.

While delta still dominates, the CDC says omicron is quickly gaining ground. Dr. Harrison said it's only a matter of time before omicron is detected in Western Pennsylvania. With limited sequencing, it could already be circulating here. “I’m certain it'll be uncovered relatively soon.”

Emily Mullin is a freelance health reporter.

First Published: December 17, 2021, 5:15 p.m.
Updated: December 17, 2021, 5:26 p.m.

RELATED
Child life specialist Colleen O'Connor and registered nurse Melony Wilhelm give Xander Rivera, 6, of Monroeville, a COVID-19 Pfizer vaccine at Children's Hospital, Friday, Nov. 19, 2021, in Lawrenceville.
Hallie Lauer and Kellen Stepler
'A manmade crisis': Pa. hospitals overflowing with COVID patients, mostly unvaccinated
A boy receives a dose of Pfizer-BioNTech COVID-19 vaccination for children ages 5 to 11 on Wednesday in Rome. Italy has started vaccinating children aged 5-11 against COVID-19 as the government braces for the spread of the omicron variant during the holiday season.
Samuel Petrequin
Omicron to be dominant variant in EU by mid-January
SHOW COMMENTS (11)  
Join the Conversation
Commenting policy | How to Report Abuse
If you would like your comment to be considered for a published letter to the editor, please send it to letters@post-gazette.com. Letters must be under 250 words and may be edited for length and clarity.
Partners
Advertisement
Mayor Ed Gainey during  a press conference at the Downtown Public Safety Center on Thursday. He angrily criticized what he believes negative media coverage of his work as mayor.
1
opinion
Brandon McGinley: ‘The wheels are coming off’ the Gainey administration
Pittsburgh Penguins fans hold up cards for recently retired Hockey Hall of Fame announcer Mike Lange in a tribute him during a break in the first period of the team's NHL hockey game against the Dallas Stars, Tuesday, Oct. 19, 2021, in Pittsburgh.
2
sports
Mike Sullivan, longtime Penguins players reflect on life and legacy of Mike Lange
Two slices of New York-style pizza and one cut of Sicilian at Etna Slice House in Etna.
3
life
Etna Slice House is 'closed until further notice' following pizzaiolo's departure
Longtime KDKA-TV host Jon Burnett on May 22, 2019.
4
a&e
Jon Burnett, long a KDKA-TV staple, leaves legacy of ‘putting good out into the world’
Cars drive through snow on Washington Road in Bethel Park Sunday, Feb. 16, 2025.
5
news
Pittsburgh will climb out of an Arctic cold snap and into above-average temperatures soon. Will it last?
Kristin Grant, a microbiologist on the COVID-19 team at the Washington State Department of Health's Public Health Laboratory, loads samples that tested positive for COVID-19 into a machine that prepares them for automated genome sequencing on Dec. 7 in Shoreline, Wash.  (Associated Press)
Dr. Lee Harrison, right, professor of infectious diseases and epidemiology at the University of Pittsburgh, and Alex Sundermann, a doctoral student, work with genetic sequencing equipment at Pitt that can differentiate between COVID-19 variants like omicron and delta.
Associated Press
Advertisement
LATEST news
Advertisement
TOP
Email a Story